Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects

This publication has 26 references indexed in Scilit:

• The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts
  Published by Elsevier ,2003
• Human thiopurine methyltransferase activity varies with red blood cell age
  British Journal of Clinical Pharmacology, 2001
• Detection Assay of Rare Variants of the Thiopurine Methyltransferase Gene by PCR-RFLP Using a Mismatch Primer in a Japanese Population.
  Biological & Pharmaceutical Bulletin, 2000
• Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity
  British Journal of Clinical Pharmacology, 1997
• A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell line
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
• Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
  The Lancet, 1990
• Effects of methotrexate on purine and pyrimidine metabolism and cell-kinetic parameters in human malignant lymphoblasts of different lineages
  Biochemical Pharmacology, 1988
• Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in molt-4 malignant human T-lymphoblasts
  Biochemical Pharmacology, 1986
• Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
• Discrepancies in ribonucleotide concentrations in human lymphocytes isolated from heparinized and defibrinized blood
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1985